During the process of examination of applications for marketing authorisations for veterinary medicinal products containing or consisting of genetically modified organisms as referred to in Article 8(5) of this Regulation, the Agency shall hold the necessary consultations with the bodies set up by the Union or Member States in accordance with Directive 2001/18/EC.
Le linn scrúdú a dhéanamh ar iarratais ar údaruithe margaíochta do tháirgí íocshláinte tréidliachta ina bhfuil orgánaigh ghéinmhodhnaithe amhail dá dtagraítear in Airteagal 8(5) den Rialachán seo, nó atá comhdhéanta astu, tionólfaidh an Ghníomhaireacht na comhairliúcháin is gá leis na comhlachtaí arna mbunú ag an Aontas nó ag na Ballstáit i gcomhréir le Treoir 2001/18/CE.